Cara Therapeutics Appoints Mani Mohindru, Ph.D., Chief Financial Officer
Go back to Cara Therapeutics Appoints Mani Mohindru, Ph.D., Chief Financial Officer| CARA THERAPEUTICS (NASDAQ: CARA) | Delayed: 5.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $17.69 | |||
| Open | $5.32 | 52 Week Low | $4.26 | |||
| Day High | $5.32 | P/E | N/A | |||
| Day Low | $5.32 | EPS | $-0.42 | |||
| Volume | 200 | |||||
| Curis, Inc. (NASDAQ: CRIS) | Delayed: 1.58 -0.03 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.61 | 52 Week High | $3.70 | |||
| Open | $1.63 | 52 Week Low | $1.25 | |||
| Day High | $1.66 | P/E | N/A | |||
| Day Low | $1.50 | EPS | $-0.15 | |||
| Volume | 212,135 | |||||
